Cristalia’s human growth hormone will be administered with CRISPEN®. Approved by ANVISA1, CRISPEN® is part of Nemera’s state-of-the-art pen injector platform PENDURA AD.
With a newly acquired space in Vernon Hills, Nemera opens a third location in the United States, in addition to the manufacturing facility in Buffalo Grove and Innovation center in...